CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) - Institutionelt ejerskab - Købere

Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
US ˙ NYSEAM ˙ US13471N2018

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock), omfatter .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-14 13F Bank Of America Corp /de/ 6 0
2025-08-14 13F UBS Group AG 5.515 6
2025-08-12 13F Rhumbline Advisers 57.582 50,47 60 7,14
2025-08-15 13F Captrust Financial Advisors 11.375 6,97 12 -26,67
2025-09-04 13F/A Advisor Group Holdings, Inc. 180 0
2025-08-14 13F Sabby Management, Llc 779.744 819
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-12 13F Proequities, Inc. Call 0 0
2025-08-14 13F Two Sigma Securities, Llc 16.064 17
2025-08-12 13F Proequities, Inc. 0 0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista